BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25302371)

  • 1. Single nucleotide polymorphisms at the TNFAIP3/A20 locus and susceptibility/resistance to inflammatory and autoimmune diseases.
    Mele A; Cervantes JR; Chien V; Friedman D; Ferran C
    Adv Exp Med Biol; 2014; 809():163-83. PubMed ID: 25302371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease.
    Vereecke L; Beyaert R; van Loo G
    Biochem Soc Trans; 2011 Aug; 39(4):1086-91. PubMed ID: 21787353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An enhancer element harboring variants associated with systemic lupus erythematosus engages the TNFAIP3 promoter to influence A20 expression.
    Wang S; Wen F; Wiley GB; Kinter MT; Gaffney PM
    PLoS Genet; 2013; 9(9):e1003750. PubMed ID: 24039598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
    Das T; Chen Z; Hendriks RW; Kool M
    Front Immunol; 2018; 9():104. PubMed ID: 29515565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
    Vereecke L; Beyaert R; van Loo G
    Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus.
    Musone SL; Taylor KE; Lu TT; Nititham J; Ferreira RC; Ortmann W; Shifrin N; Petri MA; Kamboh MI; Manzi S; Seldin MF; Gregersen PK; Behrens TW; Ma A; Kwok PY; Criswell LA
    Nat Genet; 2008 Sep; 40(9):1062-4. PubMed ID: 19165919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between BANK1 and TNFAIP3 gene polymorphisms and systemic lupus erythematosus: a meta-analysis.
    Fan Y; Tao JH; Zhang LP; Li LH; Ye DQ
    Int J Immunogenet; 2011 Apr; 38(2):151-9. PubMed ID: 21208380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional effect of polymorphisms in the promoter of TNFAIP3 (A20) in acute pancreatitis in the Han Chinese population.
    Liu Y; Dan G; Wu L; Chen G; Wu A; Zeng P; Xu W
    PLoS One; 2014; 9(7):e103104. PubMed ID: 25050625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFAIP3 Gene Polymorphisms in Three Common Autoimmune Diseases: Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Primary Sjogren Syndrome-Association with Disease Susceptibility and Clinical Phenotypes in Italian Patients.
    Ciccacci C; Latini A; Perricone C; Conigliaro P; Colafrancesco S; Ceccarelli F; Priori R; Conti F; Perricone R; Novelli G; Borgiani P
    J Immunol Res; 2019; 2019():6728694. PubMed ID: 31534975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity.
    Koumakis E; Giraud M; Dieudé P; Cohignac V; Cuomo G; Airò P; Hachulla E; Matucci-Cerinic M; Diot E; Caramaschi P; Mouthon L; Riccieri V; Cracowski JL; Tiev KP; Francès C; Amoura Z; Sibilia J; Cosnes A; Carpentier P; Valentini G; Manetti M; Guiducci S; Meyer O; Kahan A; Boileau C; Chiocchia G; Allanore Y
    Arthritis Rheum; 2012 Aug; 64(8):2746-52. PubMed ID: 22488580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic activation of NF-κB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk.
    Kim T; Bae SC; Kang C
    Arthritis Res Ther; 2020 Apr; 22(1):93. PubMed ID: 32334614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus.
    Adrianto I; Wen F; Templeton A; Wiley G; King JB; Lessard CJ; Bates JS; Hu Y; Kelly JA; Kaufman KM; Guthridge JM; Alarcón-Riquelme ME; ; Anaya JM; Bae SC; Bang SY; Boackle SA; Brown EE; Petri MA; Gallant C; Ramsey-Goldman R; Reveille JD; Vila LM; Criswell LA; Edberg JC; Freedman BI; Gregersen PK; Gilkeson GS; Jacob CO; James JA; Kamen DL; Kimberly RP; Martin J; Merrill JT; Niewold TB; Park SY; Pons-Estel BA; Scofield RH; Stevens AM; Tsao BP; Vyse TJ; Langefeld CD; Harley JB; Moser KL; Webb CF; Humphrey MB; Montgomery CG; Gaffney PM
    Nat Genet; 2011 Mar; 43(3):253-8. PubMed ID: 21336280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
    Sisto M; Barca A; Lofrumento DD; Lisi S
    Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tag polymorphisms at the A20 (TNFAIP3) locus are associated with lower gene expression and increased risk of coronary artery disease in type 2 diabetes.
    Boonyasrisawat W; Eberle D; Bacci S; Zhang YY; Nolan D; Gervino EV; Johnstone MT; Trischitta V; Shoelson SE; Doria A
    Diabetes; 2007 Feb; 56(2):499-505. PubMed ID: 17259397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A20: linking a complex regulator of ubiquitylation to immunity and human disease.
    Ma A; Malynn BA
    Nat Rev Immunol; 2012 Nov; 12(11):774-85. PubMed ID: 23059429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, biological activities and mechanisms of action of A20 (TNFAIP3).
    Verstrepen L; Verhelst K; van Loo G; Carpentier I; Ley SC; Beyaert R
    Biochem Pharmacol; 2010 Dec; 80(12):2009-20. PubMed ID: 20599425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Low Expression of A20 in Tumor Necrosis Factor-α-stimulated SLE Monocytes Mediates Sustained NF-κB Inflammatory Response.
    Shi X; Qian T; Li M; Chen F; Chen Y; Hao F
    Immunol Invest; 2015; 44(5):497-508. PubMed ID: 26107748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The polymorphisms of tumor necrosis factor-induced protein 3 gene may contribute to the susceptibility of chronic primary immune thrombocytopenia in Chinese population.
    Zhou H; Yang J; Liu L; Zhang D; Zhou K; Li H; Zhao H; Han L; Zhou J; Liu X; Song Y; Yang R
    Platelets; 2016; 27(1):26-31. PubMed ID: 25806576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population.
    Dieudé P; Guedj M; Wipff J; Ruiz B; Riemekasten G; Matucci-Cerinic M; Melchers I; Hachulla E; Airo P; Diot E; Hunzelmann N; Cabane J; Mouthon L; Cracowski JL; Riccieri V; Distler J; Meyer O; Kahan A; Boileau C; Allanore Y
    Ann Rheum Dis; 2010 Nov; 69(11):1958-64. PubMed ID: 20511617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Context-dependent cooperation between nuclear factor κB (NF-κB) and the glucocorticoid receptor at a TNFAIP3 intronic enhancer: a mechanism to maintain negative feedback control of inflammation.
    Altonsy MO; Sasse SK; Phang TL; Gerber AN
    J Biol Chem; 2014 Mar; 289(12):8231-9. PubMed ID: 24500711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.